Investigation of benign prostatic hyperplasia

Current Opinion in Urology

Volumn 13, Issue 1, 2003, Pages 17-22

  Tubaro, Andrea ^a   Trucchi, Alberto ^a   Miano, Lucio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Diagnosis; Prostatic hyperplasia; Signs and symptoms; Urinary tract

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANAMNESIS; CHRONIC PROSTATITIS; CLINICAL PRACTICE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HUMAN; MEDICAL DECISION MAKING; NOCTURIA; PATHOPHYSIOLOGY; PEER REVIEW; PREDICTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REVIEW; SEXUAL FUNCTION; SYMPTOMATOLOGY; URINARY TRACT DISEASE;

AGED; DISEASE PROGRESSION; ENDOSONOGRAPHY; GUIDELINES; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PHYSICAL EXAMINATION; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; URINATION DISORDERS; URODYNAMICS;

EID: 0037241964     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200301000-00004     Document Type: Review

References (36)

1. Chatelain CH, Denis L, Foo KT, et al. Evaluation and treatment of lower urinary tract symptoms in older men. Recommendations of the 5th International Consultation on Benign Prostatic Hyperplasia; June 25-28, 2000; Paris. Plymouth, UK: Health Publication Ltd; 2001, pp. 519-533.
2. De la Rosette JJMCH, Alivizatos G, Madersbacher S, et al. EAU guidelines on benign prostatic hyperplasia (BPH). Eur Urol 2001; 40:256-263.
3. De la Rosette JJMCH, van der Schoot DKE, Debruyne FMJ. Recent developments in guidelines on benign prostatic hyperplasia. Curr Op Urol; 2002:12:3-6.
4. Kim HL, Stern SD, Gerber GS. Practice trends in the management of prostate disease by family physicians and general internist: an internet based-survey. Urology, 2002; 59:266-271.
5. Lepor H, Machi G. Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age. Urology, 1993; 42:36-40.
6. Chai TO, Belville WD, McGuire EJ, et al. Specificity of the American Urological Association voiding symptom index: comparison of unselected and selected samples of both sexes. J Urol, 1993; 150:1710-1713.
7. Barry MJ. Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia. Urology, 2001; 58:25-32.
8. Tan MO, Diker Y, Uygur MC, et al. Are clinical characteristics of familial benign prostatic hyperplasia different than in sporadic cases. Urol Int, 2002; 68:68-178.
9. Jolleys JV, Donovan JL, Nanchahal K, et al. Urinary symptoms in the community: how bothersome are they? Br J Urol, 1994; 74:551-5
10. Matthiesen T, Ritting S, Norgaard JP, et al. Nocturnal polyuria and natriuresis in male patients with nocturia and lower urinary tract symptoms. J Urol, 1996; 156:1292-1299.
11. Homma Y, Yamaguchi T, Kondo Y, et al. Significance of nocturia in the international prostate symptom score for benign prostatic hyperplasia. J Urol, 2002; 167:172-176.
12. Bertaccini A. Vassallo F, Martino F, et al. Symptoms, bothersomeness and quality of life in patients with LUTS suggestive of BPH. Eur Urol, 2001; 40:13-18.
13. Kaplan SA, Ikeguchi EF, Santarosa RP, et al. Etiology of voiding dysfunction in men less than 50 years of age. Urology 1996; 47:836-839.
14. McNaughton Collins M, Meigs JB, Barry MJ, et al. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol, 2002; 167:1363-1366.
15. Litwin MS, McNaughton Collins M, Fowler FJ Jr, et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of an new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol; 1999: 162:369-375.
16. Kunishima Y, Mtsukawa M, Takahashi S, et al. National institutes of health chronic prostatitis symptom index for Japanese men. Urology, 2002; 60:74-77.
17. Djavan B. Nickel JC, de la Rosette J, Abrams P. The urologist view of BPH progression: results of an international survey. Eur urol, 2002; 41:490-496.
18. Roehrborn CG, McConnell JD, Saltzman B, et al. Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcome. Eur Urol, 2002; 42:1-6.
19. Green JS, Holden ST, Bose P, et al. An investigation into the relationship between prostate size, peak urinary flow rate and male erectile dysfunction. J Impot Res. 2001; 13:322-5.
20. Leliefeld HHJ, Stoevelaar HJ, McDonnell J. Sexual function before and after various treatment for symptomatic benign prostatic hyperplasia. BJU International; 2002;89:208-213.
21. Hozneck A, Abbou CC. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function. Curr Urol Rep. 2001; 2:311-317.
22. Tubaro A, Polito M, Giambroni L, et al. Sexual function in patients with LUTS suggestive of BPH. Eur Urol, 2001; 40 Suppl. 1:19-22.
23. Brookes A, Donovan JL, Peters TJ, et al. Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trials. BMJ 2002; 324:1059-1065.
24. Talic RF. Erectile dysfunction following high-energy thick look prostatectomy. Scand J Urol Nephrol, 2001; 35:300-304.
25. Peters TJ, Donovan JL, Kay HE, et al. The International Continence Society 'Benign Prostatic Hyperplasia' Study: the bothersomeness of urinary symptoms. J Urol, 1997; 157:885-889.
26. Sanchez ASS, Millan IRH, Martin MS, et al. The impact of benign prostatic hyperplasia surgery on patients' quality of life. Urol Int, 2002; 68:32-37.
27. Barry MJ, Fowler FJ Jr, O'Leary MP, et al. Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement committee of the American Urological Association. Med Care 1995; 33(4 Suppl):AS145-155.
28. Schultz MW, Chen J, Woo HH, et al. A comparison of techniques for eliciting patient preference in patients with benign prostatic hyperplasia. J Urol, 2002; 168:155-159.
29. O'Leary MP. Quality of life and alpha-blocker therapy: an important consideration for both the patient and the physician. Urology. 2002; 59(2 Suppl 1):7-11.
30. Mimata H, Satoh F, Ohno H, et al. Clinical characteristics of α-blocker responders in men with benign prostatic hyperplasia. Urol Int, 2001; 68:237-242.
31. Wright EJ, Fang J, Mercer EJ, et al. Prostate specific antigen predicts the long-term risk of prostate enlargement: results from the Baltimore longitudinal Study of Aging. J Urol, 2002; 167:2484-2488.
32. Thompson IM, Leach R. Editorial Comment to Prostate Specific antigen predicts the long-term risk of prostate enlargement: results from the Baltimore longitudinal study of aging. Wright EJ, Fang J, Metter EJ, et al. Prostate specific antigen predicts long-term risk of prostate enlargement: results from the Baltimore longitudinal study of aging. J Urol, 2002; 167: 2484-2488.
33. Choi J, Ikeguchi EF, Lee SW, et al. Is the higher prevalence of benign prostatic hyperplasia related to lower urinary tract symptoms in Korean men due to a high transition zone index? Eur Urol, 2002; 42:7-11
34. Wadie BS, Ebrahim E-H E, Gomha MA. The relationship of detrusor instability and symptoms with objective parameters used for diagnosing bladder outlet obstruction: a prospective study. J Urol, 2002; 168:132-134.
35. van Verooij GEPM, Eckhardt MD, Gisolf KWH, Boon TA. Data from frequency-volume charts versus filling cystometric estimated capacities and prevalence of instability in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Neurourol Urodyn, 2002; 10:106-111.
36. Ichiyanagi O, Sasagawa I, Suzuki Y, et al. Relationship between the shape of passive urethral resistance relation and prostatic histology in patients with benign prostatic hyperplasia. Urol Int, 2002; 68:243-245.